SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-007426
Filing Date
2022-02-23
Accepted
2022-02-23 17:45:34
Documents
2
Period of Report
2022-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4290
2 EX-24 DOCUMENT attachment1.htm EX-24 4817
  Complete submission text file 0000899243-22-007426.txt   10509
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Issuer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10 ALLEN STREET HANOVER NH 03755
Business Address
Ferneau Philip (Reporting) CIK: 0001814202 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39696 | Film No.: 22665276